Top News
Elderly Patients With Breast Cancer and CVD Risk Factors Found More Likely to Visit ER
Can BRCA-Positive Patients With Breast Cancer Safely Become Pregnant?
The Role of Metastasectomy for Melanoma Reexamined in the Modern Era
Poor Oral Health Not Linked to Gastrointestinal Cancer Risk
Number of Comorbidities Linked to Risk of Thromboembolism in Leukemia, Lymphoma
Gait Speed Effectively Predicts Clinical Outcomes in Older Patients With Hematologic Cancers
ASCO Integrates Results from TAILORx into ASCO Clinical Practice Guideline
Predicting Bleeding Risk in Acute Myeloid Leukemia With Thrombocytopenia With Platelet Function Tests
Neoadjuvant Combo Reduces Volume of High-Risk Prostate Tumors
EDITORIAL ADVISORY BOARD
E. David Crawford, MD
Jeffrey M. Farma, MD
Featured
-
Multidisciplinary Genetic Tumor Boards: Critical for Interpreting Tumor-Only Sequencing Results
One approach for improving recommendations based on tumor-only sequencing is use of a multidisciplinary genomic tumor board, in which researchers from a variety of backgrounds weigh in on the best way to interpret test results. -
A Glossary of Cancer Terms for Patients
This fact sheet provides the meaning of oncology lingo that patients may commonly hear following a cancer diagnosis. -
The Role of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma
Updated guidelines advised against performing cytoreductive nephrectomy in poor-risk patients. -
Tumors With High Levels of Microsatellite Instability Responded Well to Treatment With PD-1 Inhibitors
New research has linked microsatellite instability and the number of insertion/deletion mutations present in a tumor to clinical response to checkpoint inhibition. -
Research Shows How Talc Powder May Change Ovarian Cancer Cells
Prospective studies on talc and cancer are necessary to fully form our collective understanding of talc’s risks. -
Next-Generation Sequencing for Patients: What Test Will I Get?
This fact sheet describes some of the panels used to detect genomic aberrations and guide treatment decisions.
More Features
Evaluating the Cost-Effectiveness of Acute Myeloid Leukemia Treatment
The approval of novel oral therapeutic agents may offer a more cost-effective treatment option for acute myeloid leukemia.
The Revival of a Forgotten Cancer Gene Therapy With Off-the-Shelf Potential
A universal cancer gene therapy from the early 2000s is headed into phase 2 trials, in light of renewed interest and outlier patients who are still alive at 10 years later.
Looking Back to Go Forward: CAR-T Cell Therapy in R/R CLL
Research suggests that ibrutinib may have the ability to alter the phenotype of a final CAR-T cell product.
IL-2 and Metastatic Renal Cell Carcinoma
Despite a challenging toxicity profile, high dose interleukin-2 (HD IL-2), one of the earliest-approved immunotherapies for metastatic renal cell carcinoma still has a role in treating selected patients, a new registry analysis shows.
Screening Beyond 5 Years Reduces Risk of Lung Cancer-Specific Mortality by 39%
An Italian trial reported fewer deaths with annual or biennial low-dose CT lung screening—and an active surveillance approach reduced overdiagnosis.
